Goutam Rath

Goutam Rath

Auto-generated profile, based on publicly available information

Goutam Rath

Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2017 in Journal of Drug Targeting
Verified
Journal Article
Closed access
ASAnkush Sharma
Ankush Sharma
AGAmit K. Goyal
Amit K. Goyal
GRGoutam Rath
Goutam Rath
Metal nanoparticles (NPs) may have the potential to overcome problems related to conventional chemotherapy. Metal NPs reported to play a beneficial and powerful role in cancer therapy providing better targeting, gene silencing and drug delivery. Functionalised metal NPs with targeting ligands offer a better control of energy deposition in the tumours. Apart from therapeutic benefits, metal NPs are also used as a diagnostic tool for the imaging of cancer cells. Metal NP-based therapeutic systems not only provide simultaneous diagnostic and therapy but also allow controlled and targeted drug release which helps to revolutionise cancer treatment and management. This review addresses the advancement of metal NPs in tumour therapy with a focus on those being explained into clinical settings.

1 July 2020 in Archives of Medical Research
Verified
Journal Article
Closed access
DPDeepak Pradhan
Deepak Pradhan
PBPrativa Biswasroy
Prativa Biswasroy
PNPradeep Kumar Naik
Pradeep Kumar Naik
GGGoutam Ghosh
Goutam Ghosh
GRGoutam Rath
Goutam Rath

1 April 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ACAkshay Chandel
Akshay Chandel
AGAmit K. Goyal
Amit K. Goyal
GGGoutam Ghosh
Goutam Ghosh
GRGoutam Rath
Goutam Rath
Pulmonary route is extensively studied for the diagnosis and treatment of pulmonary and extra pulmonary disease conditions such as asthma, tuberculosis, emphysema, and bronchitis. Formulation design, inhalation device and particle size play key role in determining the aerosol performance. The lack of desired clinical outcome along with the problem regarding efficacy or any adverse drug effect may arise due to improper training and education in use of the device to control the actuation and aerosol inhalation. This review summarizes the difference in the mechanistic features of current marketed aerosol delivery devices with respect to mechanism of aerosol generation with possible advancements in the aerosol design. The delivery options in the pulmonary route and its merits together with the limitations are also discussed. An update is provided regarding the current research and clinical outcome of the use of inhalational technology.

1 August 2020 in Heliyon
Verified
Journal Article
Open access
AGAbhinava Garg
Abhinava Garg
GSGanti S. Sharma
Ganti S. Sharma
AGAmit K. Goyal
Amit K. Goyal
GGGoutam Ghosh
Goutam Ghosh
SSSudam Chandra Si
Sudam Chandra Si
GRGoutam Rath
Goutam Rath
Fungal skin infections are the most common global issue for skin health. Fungal infections are often treated by topical or systemic anti-fungal therapy. Topical fungal therapy is usually preferred because of their targeted therapy and fewer side effects. Advanced topical carriers because of their distinct structural and functional features, overcome biopharmaceutical challenges associated with conventional drug delivery systems like poor retention and low bioavailability. Literature evidence indicated topical nanocarriers loaded with anti-fungal agents display superior therapeutic response with minimum toxicity. Nanocarriers often used for topical anti-fungal medication includes Solid-Lipid nanoparticles, Microemulsions, Liposomes, Niosomes, Microsponge, Nanogel, Nanoemulsion, Micelles etc. This review summarizes recent advances in novel strategies employed in topical carriers to improve the therapeutic performance of anti-fungal drugs.

20 July 2022 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
AMAjit Mishra
Ajit Mishra
DPDeepak Pradhan
Deepak Pradhan
JHJitu Halder
Jitu Halder
PBPrativa Biswasroy
Prativa Biswasroy
VRVineet Kumar Rai
Vineet Kumar Rai
GRGoutam Rath
Goutam Rath

1 February 2022 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
JHJitu Halder
Jitu Halder
DPDeepak Pradhan
Deepak Pradhan
BKBiswakanth Kar
Biswakanth Kar
GGGoutam Ghosh
Goutam Ghosh
GRGoutam Rath
Goutam Rath